Botanix Pharmaceuticals (BOT) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock BOT Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Botanix Pharmaceuticals Issues New Warrants to Strengthen Market PositionJune 11, 2025 | tipranks.comHealth Check: Little Green Pharma’s European success is more than pot luckJune 10, 2025 | msn.comWhy Austal, Botanix, DroneShield, and NextDC shares are storming higher todayJune 10, 2025 | msn.comBotanix Pharmaceuticals Secures A$48 Million Debt Facility for GrowthJune 9, 2025 | tipranks.comAs AI rewires microbiology, Clever Culture’s lab tech is catching Big Pharma’s eyeMay 29, 2025 | msn.comFinding the share market's next growth winners, and a biotech to watchMay 26, 2025 | msn.comBotanix Pharmaceuticals Expands Market Presence with New Securities QuotationMay 21, 2025 | tipranks.comWhy AVITA, Botanix, Brainchip, and NAB shares are falling todayMay 13, 2025 | msn.comBotanix Pharmaceuticals Addresses Potential Impact of US Drug Pricing PolicyMay 11, 2025 | tipranks.comInsignia Financial Reduces Stake in Botanix PharmaceuticalsMay 6, 2025 | tipranks.comBotanix Pharmaceuticals Expands Market Presence with New Securities QuotationApril 24, 2025 | tipranks.comBotanix Pharmaceuticals Raises A$40 Million Through Share PlacementApril 24, 2025 | tipranks.comHealth Check: Trump says a pharma tax is in the offing – with no negotiationApril 15, 2025 | msn.comBotanix Pharmaceuticals Secures $40 Million to Boost Sofdra™ RolloutApril 14, 2025 | tipranks.comBotanix Pharmaceuticals Hosts Webinar on Sofdra Launch and Strategic UpdatesApril 14, 2025 | tipranks.comBotanix Pharmaceuticals taps investors for $40m; Euroz, E&P in towApril 14, 2025 | afr.com3 reasons to buy this surging ASX All Ords healthcare share todayApril 2, 2025 | msn.comBotanix Pharmaceuticals Issues New Securities as Part of Employee Incentive SchemeApril 2, 2025 | tipranks.comThese fundies outperformed this quarter thanks to gold and small capsMarch 31, 2025 | afr.comASX Growth Stocks With High Insider Ownership That Stand OutMarch 25, 2025 | finance.yahoo.comThe ASX pharmas playing the long game, with commercialisation the prizeMarch 18, 2025 | msn.comBotanix climbs into ASX 300 club, strengthening its global dermatology ambitionsMarch 13, 2025 | msn.comLong Shortz with Botanix Pharmaceuticals : a new major milestoneMarch 11, 2025 | msn.comHealth Check: Poly oh no! Polynovo shares resume slide as CEO goesMarch 10, 2025 | msn.comBotanix Pharmaceuticals Releases Business Overview and Forward-Looking StatementsMarch 10, 2025 | tipranks.comAnalysts Are Optimistic We'll See A Profit From Botanix Pharmaceuticals Limited (ASX:BOT)March 7, 2025 | finance.yahoo.comBotanix Pharmaceuticals Director Alters Shareholding StructureFebruary 27, 2025 | tipranks.comBotanix Pharmaceuticals Issues New Shares for Immediate TradingFebruary 27, 2025 | tipranks.comThis media company’s share price is tipped to doubleJanuary 23, 2025 | afr.comBotanix Pharmaceuticals’ Chair Adjusts Shareholding Amidst Strategic GrowthJanuary 16, 2025 | tipranks.comInsignia Financial Reduces Stake in Botanix PharmaceuticalsJanuary 14, 2025 | tipranks.comShenasaby Investments Ceases to be Substantial Holder in Botanix PharmaceuticalsJanuary 9, 2025 | tipranks.comBotanix Pharmaceuticals Issues New Unquoted Securities to Boost Employee IncentivesJanuary 9, 2025 | tipranks.comBotanix Pharmaceuticals Updates Director’s ShareholdingJanuary 9, 2025 | tipranks.com5 ASX All Ords shares starting the new year at 52-week highsJanuary 2, 2025 | msn.comFirst Sofdra prescriptions for excessive sweating condition pushes Botanix towards full commercial launchDecember 17, 2024 | msn.comHealth Check: Clinical trials don’t sleigh down for the silly seasonDecember 17, 2024 | msn.comBotanix Pharmaceuticals Prepares for Sofdra™ Market LaunchDecember 16, 2024 | tipranks.comAxillary Hyperhidrosis Treatment Market 2032: Clinical Trials, EMA, PDMA, FDA Approvals, Medication, Patient Pool, and Companies DelveInsightDecember 12, 2024 | theglobeandmail.comThis ASX biotech stock could be the next M&A targetDecember 5, 2024 | afr.comBotanix Pharmaceuticals: Director’s Stock Interests SurgeDecember 3, 2024 | tipranks.comBotanix Pharmaceuticals Lists New Securities on ASXDecember 2, 2024 | tipranks.comThose who invested in Botanix Pharmaceuticals (ASX:BOT) three years ago are up 443%November 20, 2024 | finance.yahoo.comBotanix Pharmaceuticals to Present at Key Healthcare ConferenceNovember 19, 2024 | markets.businessinsider.comBotanix Pharmaceuticals Expands Sofdra™ Coverage in USNovember 14, 2024 | markets.businessinsider.comBiocurious: No sweat as Botanix tackles the world’s third-biggest skin disorderNovember 13, 2024 | msn.comBotanix Pharmaceuticals Passes Key AGM ResolutionsNovember 4, 2024 | markets.businessinsider.comBotanix Pharmaceuticals Poised for Market Impact with Sofdra LaunchNovember 3, 2024 | tipranks.comBotanix Pharmaceuticals Prepares for Sofdra LaunchOctober 28, 2024 | markets.businessinsider.comHere's Why We're Not At All Concerned With Botanix Pharmaceuticals' (ASX:BOT) Cash Burn SituationOctober 24, 2024 | finance.yahoo.com Get Botanix Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for BOT and its competitors with MarketBeat's FREE daily newsletter. Email Address BOT Media Mentions By Week BOT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BOT News Sentiment▼0.200.56▲Average Medical News Sentiment BOT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BOT Articles This Week▼01▲BOT Articles Average Week Get Botanix Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for BOT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Genus News Today Oxford Nanopore Technologies News Today Biotest Aktiengesellschaft News Today Zenas Biopharma News Today PureTech Health News Today Oxford Biomedica News Today Faron Pharmaceuticals Oy News Today Fennec Pharmaceuticals News Today Cybin News Today NervGen Pharma News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:BOT) was last updated on 6/18/2025 by MarketBeat.com Staff From Our PartnersAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump Makes Major Crypto AnnouncementPay close attention to what I'm about to share… Most investors think Trump's pro-crypto policies will lift ...Crypto 101 Media | SponsoredWill I be blacklisted?The President’s tour of the Middle East… the deal for Ukraine’s mineral rights… Elon’s strange time in Washing...Porter & Company | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMost Bitcoin holders have no idea this existsHere’s what 99% of Bitcoin holders don’t know: There’s a way to amplify your Bitcoin gains without buying m...Brownstone Research | SponsoredElon’s End Game Is Going Live -- And It Could Make You a FortuneThe media and the so-called experts have laughed at Elon Musk his entire career. CBS called PayPal “one of ...The Oxford Club | SponsoredSorry about the swear wordWhat a huge few months for Bitcoin. First, Bitcoin hit $100,000… Then, Donald Trump pledged to create an...Manward Press | SponsoredGold Just Jumped Again. Here’s How to Get PaidGold prices just spiked again. As I write this, gold is trading near $3,400 an ounce. But here's the thi...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Botanix Pharmaceuticals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Botanix Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
